GB2159715B - Pharmaceutical composition in sustained release unit dose form and process for its preparation - Google Patents

Pharmaceutical composition in sustained release unit dose form and process for its preparation

Info

Publication number
GB2159715B
GB2159715B GB08513641A GB8513641A GB2159715B GB 2159715 B GB2159715 B GB 2159715B GB 08513641 A GB08513641 A GB 08513641A GB 8513641 A GB8513641 A GB 8513641A GB 2159715 B GB2159715 B GB 2159715B
Authority
GB
United Kingdom
Prior art keywords
preparation
pharmaceutical composition
sustained release
unit dose
release unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08513641A
Other versions
GB2159715A (en
GB8513641D0 (en
Inventor
Paul Jonathan Harrison
John Richard Langridge
Christopher John Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterwin AG
Original Assignee
Sterwin AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848414220A external-priority patent/GB8414220D0/en
Application filed by Sterwin AG filed Critical Sterwin AG
Priority to GB08513641A priority Critical patent/GB2159715B/en
Publication of GB8513641D0 publication Critical patent/GB8513641D0/en
Publication of GB2159715A publication Critical patent/GB2159715A/en
Application granted granted Critical
Publication of GB2159715B publication Critical patent/GB2159715B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
GB08513641A 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation Expired GB2159715B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08513641A GB2159715B (en) 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form
GB08513641A GB2159715B (en) 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation

Publications (3)

Publication Number Publication Date
GB8513641D0 GB8513641D0 (en) 1985-07-03
GB2159715A GB2159715A (en) 1985-12-11
GB2159715B true GB2159715B (en) 1988-05-05

Family

ID=26287812

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08513641A Expired GB2159715B (en) 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation

Country Status (1)

Country Link
GB (1) GB2159715B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE450087B (en) * 1985-10-11 1987-06-09 Haessle Ab GRAINS WITH CONTROLLED RELEASE OF PHARMACIFICALLY ACTIVE SUBSTANCES APPLIED SIGNED ON A COMPACT INSULABLE NUCLEAR MATERIAL
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
SE8703881D0 (en) * 1987-10-08 1987-10-08 Haessle Ab NEW PHARMACEUTICAL PREPARATION
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313915A1 (en) * 1976-01-26 1977-01-07 Corneille Gilbert Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating

Also Published As

Publication number Publication date
GB2159715A (en) 1985-12-11
GB8513641D0 (en) 1985-07-03

Similar Documents

Publication Publication Date Title
ZA895588B (en) Intravenou pharmaceutical composition and process for preparing the same
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
IL95120A0 (en) Preparation of a pharmaceutical composition in the form of microparticles
HUT54491A (en) Quickly soluble pharmaceutical unit dosage and process for producing same
HUT57202A (en) Process for producing new pharmaceutically active 5-fluoro-2-///4-/cyclopropyl-methoxy/-2-pyridinyl/-methyl-sulfonyl/-1h-benzimidazol and pharmaceutical compositions containing them
GB2149413B (en) Sustained release pharmaceutical tablets and process for the preparation thereof
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
HUT57237A (en) Process for producing glucosaminoglucanic salts and pharmaceutical compositions comprising same
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
EG17710A (en) Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them
LTIP249A (en) Pharmaceutical composition and process for the preparation thereof
HK1000597A1 (en) Pyridazine derivatives process for their preparation and pharmaceutical compositions containing them
GB2159715B (en) Pharmaceutical composition in sustained release unit dose form and process for its preparation
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
DE3568985D1 (en) Retinoic-acid derivatives, process for their preparation and medicinal and cosmetic compositions containing them
PH21022A (en) Phenylquinoline derivatives and pharmaceutical composition containing said compounds
IL84104A0 (en) Sustained release pharmaceutical compositions and their preparation
IL93986A0 (en) Improvements in and relating to pharmaceutical formulations
EP0166356A3 (en) 2-substituted-aminomethyl-1,4-benzodiazepines, process for their preparation and pharmaceutical compositions containing them
GB2209669B (en) Pharmaceutical composition containing high drug load and method for preparing same
IL88697A0 (en) Oral dosage units for pharmaceuticals and their use and preparation
NZ228789A (en) Benzothiazepin-4-one derivatives and pharmaceutical compositions; processes for preparation
EP0493526A4 (en) Stable therapeutic radionuclide compositions and methods for preparation thereof
GB2195247B (en) Transdermal laminated pharmaceutical compositions having prolonged effect and process for the preparation thereof
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930530